Panaxium to Present Novel Neural Interface Data at Asilomar Bioelectronic Symposium 2022

Interactive symposium with leading experts and rising stars in the field will focus on defining the frontiers of bioelectronics and mapping future directions.

Aix-en-Provence, FRANCE, and Toronto, CANADA, September 6, 2022 – Bioelectronic medicine company Panaxium will present “Safe neurostimulation with PEDOT:PSS coated platinum electrodes for primary cortical cells in vitro” at the Asilomar Bioelectronic Symposium in Pacific Grove, California on September 7, 2022. 

 

The field of bioelectronics seeks to explore the interfaces between electronics, materials science, biochemistry, biophysics, and general biology. Bioelectronic medicine is an emerging scientific field that aims to tackle many debilitating and degenerative medical conditions and injuries by leveraging the newest bioelectronics and building imperceptible devices at the microscale dimensions of individual cells. 

Neurostimulation has proven successful in a wide range of clinical applications such as deep brain stimulation (DBS) for movement disorders, spinal cord stimulation for chronic pain and implants for deafness. Recent advances such as retina implants and DBS for traumatic brain injuries, schizophrenia and drug addiction demonstrate the remarkable possibilities of electrical stimulation which justifies the growing interest in materials and devices to interact with biological systems. Panaxium is a precision neuro-recovery company aiming to leverage these materials to heal the diseased and injured human brain. 

“We are proud to contribute to the progress of the field of bioelectronic medicine and share some of the data confirming and refining the practical advantages of using these materials as neural interfaces,” says Dr. Brad Schmidt, PhD, Co-Founder and CEO of Panaxium. “Our team is thrilled to join such a remarkable group of experts at the symposium this week.”  

 

Presentation Details

July 7, 2022

 

Safe neurostimulation with PEDOT:PSS coated platinum electrodes for primary cortical cells in vitro

Jolien Pas¶ (1,#a,*), Gerwin Dijk¶ (2,#a), Katarina Markovic (3), Janez Scancar (3), Rodney O’Connor (2) 

  1. Panaxium SAS, France, www.panaxium.com
  2. Department of Bioelectronics, Mines Saint-Etienne, Center of Microelectronics in Provence, Gardanne, France 
  3. Department of Environmental Sciences, Jožef Stefan Institute, Ljubljana, Slovenia

(#a) Current affiliation: Department of Materials Science and Engineering, Stanford University, Stanford, CA, USA 

ABOUT PANAXIUM
Founded in 2016, Panaxium is a new and rapidly-growing bioelectronic medicine company aiming to fundamentally change the way disease is treated. The company is comprised of a multidisciplinary team of internationally-renowned scientists, including world experts in organic bioelectronics and leaders in the fields of chemistry, materials science, electrical engineering, systems design, electronic engineering, data science, biology, biochemistry, and nanotechnology. Together they are working to solve some of the most difficult and important problems in medicine. For further information, please visit http://www.panaxium.com.

Back